AI MARKET SCANNING

Immunocore Holdings plc

📅 Next Catalyst: Nov 05, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Health Technology 🏭 Biotechnology
AVG HISTORICAL GAP +0.58%
MAX GAP RECORD +6.79%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $IMCR
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 05, 2026 Earnings Release 2026-11-05 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 06, 2026 Earnings Release 2026-08-06 (BEFORE OPEN)
-1.35%
May 06, 2026 Earnings Release 2026-05-06 (BEFORE OPEN)
+3.43%
Feb 25, 2026 Earnings Release 2026-02-25 (BEFORE OPEN)
-3.50%
Nov 06, 2025 Earnings Release 2025-11-06 (BEFORE OPEN)
+0.91%
Aug 07, 2025 Earnings Release 2025-08-07 (BEFORE OPEN)
+0.16%
May 07, 2025 Earnings Release 2025-05-07 (BEFORE OPEN)
+6.74%
Feb 26, 2025 Earnings Release 2025-02-26 (BEFORE OPEN)
-4.14%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.8%
Bullish Gaps (5)
Bearish Gaps (5)
Neutral / Flat (5)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $IMCR

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-30 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 1156m +11.88%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Immunocore Holdings Plc operates as a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease. the firm's lead product KIMMTRAK is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma,…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗